Sign inJoin waitlistJoin the waitlist

Ibrahim Aldoss

Clinical Trials Medical Director, Comprehensive Cancer Center, City of Hope, Duarte, CA · City of Hope National Medical Center

Credentials: · · · ·

History

Comprehensive Cancer Center · City of Hope National Medical Center
Present
City of Hope National Medical Center
Present
City of Hope National Medical Center
Present

University of Southern California
2010–2013
Internal Medicine
Creighton University
2007–2010
Jordan University of Science and Technology Faculty of Medicine
2002–2006

Research

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
Nature · 2023 · 458 citations
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults
Journal of Clinical Oncology · 2017 · 358 citations
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Blood · 2021 · 271 citations

VP
Vinod Pullarkat
133 papers
Stephen Forman
114 papers
Guido Marcucci
102 papers
AS
Anthony Stein
93 papers
Ryotaro Nakamura
78 papers
AS
Amandeep Salhotra
69 papers
Monzr Al Malki
64 papers · 3 as a fellow
Haris Ali
61 papers
Ahmed Aribi
57 papers
KS
Karamjeet Sandhu
51 papers
PK
Paul Koller
49 papers
Hoda Pourhassan
44 papers

Grants

BAFF-R CAR T Cell Therapy for ALL
National Cancer Institute · R01
PI · $3.3M · Beckman Research Institute/City of Hope
2022–2027

Clinical trials

Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Principal investigator · Not yet recruiting · Phase 1
City of Hope Medical Center
2027–2028
Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Principal investigator · Recruiting · Phase 1
City of Hope Medical Center
2026–2028
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
Principal investigator · Recruiting · Early phase 1
City of Hope Medical Center
2025–2029
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
2025–2029